About this trial
This study evaluates a diagnostic serological test for Non-Tuberculous Mycobacteria (NTM) infection in cystic fibrosis patients by measuring T cell response. It aims to highlight a dynamic response associated to the pathogen's presence. This multicenter case-control study involves two populations, providing a better understanding of the circulating T-IFNγ-MNT response in these patients.
Eligibility criteria
Qualifiers
Patient ≥18 years
Patient previously included in the CIMeNT study
Patient with a confirmed diagnosis of cystic fibrosis regardless of CFTR genotype
Patient affiliated to the social security system
Disqualifiers
Lung transplant patients
Person placed under judicial protection
Pregnant and breastfeeding women
Trial design
Treatments tested in this trial
- Scheduled visit (V1)
Treatment groups
Sponsors and collaborators
University Hospital, Montpellier
Lead sponsor
Hôpital Cochin
Collaborator
Cystic Fibrosis Foundation
Collaborator